Texas Instruments: Analysts' Upgrades, Downgrades

Texas Instruments estimates increased at UBS through 2011. Company boosted guidance in its mid-quarter update.
Author:
Publish date:

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Alpha & Omega Semiconductor Limited

(AOSL) - Get Report

initiated at Thomas Weisel with an Overweight rating and $20 price target. AOSL has shown rapid growth recently through market share gains and an intense focus on the Asian consumer electronics.

Baidu

(BIDU) - Get Report

rated new Buy at ThinkEquity. $94 price target. Company is a market leader and new technology is driving accelerated growth.

Choice Hotels

(CHH) - Get Report

upgraded at JP Morgan. Rating raised to Neutral from Underweight. Maintains $31 price target and 2010 EPS estimates of $1.75.

Convio

(CNVO)

initiated at Thomas Weisel with an Overweight rating and $13 price target. Pure play way to capture non-profit shift to online giving.

Equinix

(EQIX) - Get Report

upgraded at Citigroup from Hold to Buy. $110 price target. Domestic revenue growth should improve in the second half of the year.

Entergy

(ETR) - Get Report

rated new Perform at Oppenheimer. Do not expect carbon pricing or a near-term recovery in gas prices to cause a shift toward nuclear.

F5 Networks

(FFIV) - Get Report

downgraded at Ticonderoga from Buy to Neutral. Company could be hurt by potential changes in the enterprise spending environment.

Jones Apparel

(JNY)

reinstated as Neutral at Goldman. $19 price target. Estimates also lowered, because of coast inflation.

Allscripts-Misys Healthcare Solutions

(MDRX) - Get Report

upgraded at Thomas Weisel to Overweight from Market Weight on improved near and long-term outlook. Price target jumped to $24 from $20.

Pegasystems

(PEGA) - Get Report

upgraded at Roth to Buy. Stock has lost 30% since March, and is now valued at just 2 times sales.

PAA Natural Gas Storage

(PNG)

initiated at BofA/Merrill with a Neutral rating and $25.50 price target. Growth story reflected in valuation.

Potash

(POT)

upgraded at UBS. POT was upgraded from Neutral to Buy. $112 price target. Company should see higher potash production in 2011.

Vale

(VALE) - Get Report

upgraded at UBS from Neutral to Buy. $32 price target. Risk/reward is compelling, following the recent pullback.

STOCK COMMENTS / EPS CHANGES

Best Buy

(BBY) - Get Report

price target lowered at BofA/Merrill to $44 from $50 ahead of 1Q results, which will be released on Tuesday, June 15. Maintain Neutral rating.

Boston Scientific

(BSX) - Get Report

cut from Conviction Sell List at Goldman. Stock is down 21% since March, and approaching the $5.50 price target.

Dollar General

(DG) - Get Report

price target higher at Barclays. DG price target jumped to $34 from $29 as the company is reaping benefits from its initiatives. Also, DG is being offered lots of great sites at good prices. Maintain Overweight rating.

Dick's Sporting Goods

(DKS) - Get Report

added to Top Picks Live at Citi. Company should continue to take market share, especially from TSA.

Endo Pharmaceuticals

(ENDP) - Get Report

estimates upped at Goldman through 2013. Opana ER received extended exclusivity. Buy rating and $27 price target.

Monster Worldwide

(MWW)

added to Focus List at MKM Partners. Stock is already pricing in the potential for a double-dip and margins have likely bottomed.

Norfolk Southern

(NSC) - Get Report

price target higher at Barclays: to $65 from $62 on volume strength and solid price fundamentals. Estimates raised through 2011. Maintain Overweight rating.

Time Warner Cable

(TWC)

price target jumped at Barclays to $55 from $46 given overall sector multiple expansion. 2010 and 2011 EPS estimates tweaked lower to $3.28 and $3.93, respectively. Equal Weight rating.

Texas Instruments

(TXN) - Get Report

estimates increased at UBS through 2011. Company boosted guidance in its mid-quarter update. Neutral rating and $25 price target.

Union Pacific Corp

(UNP) - Get Report

price target tweaked lower at Barclays to $83 from $85 based on reduced buyback assumptions. Maintain Equal Weight rating.

Westlake Corp

(WLK) - Get Report

price target lower at Barclays. WLK price target trimmed to $17 from $19 as prices and profit margins in the U.S. plastic markets have weakened quickly. Reiterate Underweight rating.

This article was written by a staff member of TheStreet.com.